Keyphrases
Profibrotic
100%
Myeloid Cells
100%
Scleroderma
100%
Inflammatory Monocytes
76%
MARCOS
76%
Inflammatory Macrophages
69%
Poly(lactic-co-glycolic acid) Nanoparticles
23%
Bleomycin
23%
Poly(lactic-co-glycolic acid)
15%
Pathogenic Role
15%
Inflammation
15%
Fibrosis Formation
7%
Immune Pathology
7%
Time Accumulation
7%
Fibrotic Activity
7%
Negatively Charged
7%
Biological Probes
7%
Antigen-presenting
7%
Model Developing
7%
Tissue Fibrosis
7%
Lesional
7%
Targeted Therapy
7%
Patient Identification
7%
M2 Activation
7%
Mechanism of Action
7%
Spleen
7%
Myofibroblast
7%
Monocyte-derived Macrophages
7%
Collagen
7%
Skin Biopsy
7%
Healthy Controls
7%
Biological Properties
7%
Carboxylate
7%
Lung
7%
Lesional Skin
7%
In(III)
7%
Unknown Cause
7%
Clinical Significance
7%
Glycoprotein
7%
Scavenger Receptor
7%
Developing Strategy
7%
Therapeutic Potential
7%
High Mortality
7%
Novel Therapeutics
7%
Tissue Damage
7%
Apoptosis
7%
Sequestration
7%
Genomic Studies
7%
Murine Model
7%
Patient-controlled
7%
Organ Failure
7%
Nanoparticles
7%
Innovative Strategies
7%
Fibrotic Diseases
7%
Nanoparticle Treatment
7%
Inflammatory Fibrosis
7%
Macrophage Activation
7%
Alleviation
7%
Fibrogenic
7%
Pathologic
7%
Miller
7%
Drug-like
7%
Immunology and Microbiology
Scleroderma
100%
Myeloid
100%
Macrophage
84%
MARCO
76%
Glycolic Acid
38%
Pathogenic Potential
7%
Fibrogenesis
7%
Scavenger Receptor
7%
Glycoprotein
7%
Myofibroblast
7%
Programmed Cell Death
7%
Pharmacology, Toxicology and Pharmaceutical Science
Scleroderma
100%
Polyglactin
38%
Nanoparticle
30%
Bleomycin
23%
Fibrosis
23%
Inflammation
23%
Diseases
15%
Scavenger Receptor
7%
Tissue Injury
7%
Glycoprotein
7%